Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

13.35
Delayed Data
As of Dec 07
 -0.30 / -2.20%
Today’s Change
9.80
Today|||52-Week Range
19.63
-29.63%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close13.65
Today’s open13.55
Day’s range13.10 - 13.85
Volume86,950
Average volume (3 months)124,374
Market cap$308.9M
Dividend yield5.00%
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)+45.14%
Earnings growth (this year)-28.86%
Earnings growth (next 5 years)+274.70%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
RARXRa Pharmaceuticals I...+0.06+0.44%
COCPCocrystal Pharma Inc+0.00+0.24%
MNKDMannKind Corp-0.02-3.47%
TGTXTG Therapeutics Inc0.000.00%
Data as of 3:59pm ET, 12/07/2016

Financials

Next reporting dateApril 6, 2017
EPS forecast (this quarter)-$1.27
Annual revenue (last year)$0.00
Annual profit (last year)-$70.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs